Nastorazepide, CAS [[209219-38-5]]

Produktübersicht

• Artikelname: Nastorazepide, CAS [[209219-38-5]]
• Artikelnummer: MCE-HY-17617
• Hersteller Artikelnummer: HY-17617
• Alternativnummer: MCE-HY-17617-10MG,MCE-HY-17617-5MG,MCE-HY-17617-1MG,MCE-HY-17617-50MG,MCE-HY-17617-100MG,MCE-HY-17617-10MMX1ML
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: Z-360

Produktbeschreibung

Nastorazepide (Z-360) is an orally active 1,5-benzodiazepine derivative and gastrin/CCK-2 receptor antagonist. Nastorazepide inhibits the specific binding of [3H]CCK-8 to the human CCK-2 receptor with a Ki value of 0.47 nM. Nastorazepide inhibits IL-1beta, ephrin B1, VEGF, and HIF-1alpha, reduces Akt and NR2B phosphorylation. Nastorazepide has antitumor activity against pancreatic cancer. Nastorazepide inhibits colorectal cancer liver metastasis and relieves pain[1][2][3][4][5][6][7].

Produkteigenschaften

• Molekulargewicht: 520.62
• Reinheit: 99.95
• CAS Nummer: [209219-38-5]
• Formel: C29H36N4O5
• Target-Kategorie: Akt,Cholecystokinin Receptor,Ephrin Receptor,HIF/HIF Prolyl-Hydroxylase,Interleukin Related,VEGFR

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound